Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Factors influencing the cost of prosthetic joint infection treatment.

Peel TN, Cheng AC, Lorenzo YP, Kong DC, Buising KL, Choong PF.

J Hosp Infect. 2013 Nov;85(3):213-9. doi: 10.1016/j.jhin.2013.07.012.

PMID:
24011668
2.

Early onset prosthetic hip and knee joint infection: treatment and outcomes in Victoria, Australia.

Peel TN, Cheng AC, Choong PF, Buising KL.

J Hosp Infect. 2012 Dec;82(4):248-53. doi: 10.1016/j.jhin.2012.09.005.

PMID:
23084482
3.

Cost analysis of debridement and retention for management of prosthetic joint infection.

Peel TN, Dowsey MM, Buising KL, Liew D, Choong PF.

Clin Microbiol Infect. 2013 Feb;19(2):181-6. doi: 10.1111/j.1469-0691.2011.03758.x.

4.

[Reduction of Treatment Duration in Periprosthetic Infection with a Fast-Track Concept Is Economically Not Feasible].

Lieb E, Hanstein T, Schuerings M, Trampuz A, Perka C.

Z Orthop Unfall. 2015 Dec;153(6):618-23. doi: 10.1055/s-0035-1557858. German.

PMID:
26468925
5.

Gram-negative prosthetic joint infections: risk factors and outcome of treatment.

Hsieh PH, Lee MS, Hsu KY, Chang YH, Shih HN, Ueng SW.

Clin Infect Dis. 2009 Oct 1;49(7):1036-43. doi: 10.1086/605593.

PMID:
19691430
6.

Clinical characteristics, microbiology, and outcomes of prosthetic joint infection in Taiwan.

Tsai JC, Sheng WH, Lo WY, Jiang CC, Chang SC.

J Microbiol Immunol Infect. 2015 Apr;48(2):198-204. doi: 10.1016/j.jmii.2013.08.007.

7.

Culture-negative prosthetic joint infection.

Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, Gullerud R, Osmon DR.

Clin Infect Dis. 2007 Nov 1;45(9):1113-9.

PMID:
17918072
8.

Eight years experience in treatment of prosthetic joint infections at a teaching hospital in Central Taiwan.

Tseng SW, Chi CY, Chou CH, Wang YJ, Liao CH, Ho CM, Lin PC, Ho MW, Wang JH.

J Microbiol Immunol Infect. 2012 Oct;45(5):363-9. doi: 10.1016/j.jmii.2011.12.014.

9.

Total hip arthroplasty revision due to infection: a cost analysis approach.

Klouche S, Sariali E, Mamoudy P.

Orthop Traumatol Surg Res. 2010 Apr;96(2):124-32. doi: 10.1016/j.rcot.2010.02.005.

10.

Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes.

Berbari EF, Osmon DR, Duffy MC, Harmssen RN, Mandrekar JN, Hanssen AD, Steckelberg JM.

Clin Infect Dis. 2006 Jan 15;42(2):216-23.

PMID:
16355332
11.

Prosthetic joint infection in patients with rheumatoid arthritis: an outcome analysis compared with controls.

Hsieh PH, Huang KC, Shih HN.

PLoS One. 2013 Aug 26;8(8):e71666. doi: 10.1371/journal.pone.0071666.

12.

Descriptive analysis of the economic costs of periprosthetic joint infection of the knee for the public health system of Andalusia.

Garrido-Gómez J, Arrabal-Polo MA, Girón-Prieto MS, Cabello-Salas J, Torres-Barroso J, Parra-Ruiz J.

J Arthroplasty. 2013 Aug;28(7):1057-60. doi: 10.1016/j.arth.2013.02.012.

PMID:
23523484
13.

Economic burden of periprosthetic joint infection in the United States.

Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J.

J Arthroplasty. 2012 Sep;27(8 Suppl):61-5.e1. doi: 10.1016/j.arth.2012.02.022.

PMID:
22554729
14.

Outcome of prosthetic joint infections treated with debridement and retention of components.

Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmon DR.

Clin Infect Dis. 2006 Feb 15;42(4):471-8.

PMID:
16421790
15.

Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection.

Malekzadeh D, Osmon DR, Lahr BD, Hanssen AD, Berbari EF.

Clin Orthop Relat Res. 2010 Aug;468(8):2039-45. doi: 10.1007/s11999-010-1338-0.

16.

No need to search for the source of haematogenous arthroplasty infections.

Bouvet C, Tchernin D, Seirafi M, Stern R, Lew D, Hoffmeyer P, Uçkay I.

Swiss Med Wkly. 2011 Dec 14;141:w13306. doi: 10.4414/smw.2011.13306.

17.

Polymicrobial prosthetic joint infections: risk factors and outcome.

Marculescu CE, Cantey JR.

Clin Orthop Relat Res. 2008 Jun;466(6):1397-404. doi: 10.1007/s11999-008-0230-7.

18.

Treatment of joint prosthesis infection in accordance with current recommendations improves outcome.

Betsch BY, Eggli S, Siebenrock KA, Täuber MG, Mühlemann K.

Clin Infect Dis. 2008 Apr 15;46(8):1221-6. doi: 10.1086/529436.

PMID:
18444859
19.

Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm-active antibiotics: functional outcomes, quality of life and complications.

Aboltins C, Dowsey MM, Peel T, Lim WK, Parikh S, Stanley P, Choong PF.

Intern Med J. 2013 Jul;43(7):810-5. doi: 10.1111/imj.12174.

PMID:
23656615
20.

The estimated magnitude and direct hospital costs of prosthetic joint infections in the United States, 1997 to 2004.

Hellmann M, Mehta SD, Bishai DM, Mears SC, Zenilman JM.

J Arthroplasty. 2010 Aug;25(5):766-71.e1. doi: 10.1016/j.arth.2009.05.025.

PMID:
19679438
Items per page

Supplemental Content

Support Center